Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
about
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary SyndromePolycystic ovary syndrome: do endocrine-disrupting chemicals play a role?Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainInfertility in Female Mice with a Gain-of-Function Mutation in the Luteinizing Hormone Receptor Is Due to Irregular Estrous Cyclicity, Anovulation, Hormonal Alterations, and Polycystic Ovaries.The characterization of obese polycystic ovary syndrome rat model suitable for exercise interventionEnhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.Antimullerian hormone and its receptor gene expression in prenatally androgenized female rats.Polycystic ovarian syndrome is accompanied by repression of gene signatures associated with biosynthesis and metabolism of steroids, cholesterol and lipids.Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome.Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats.Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhoodStereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats.Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic reviewCircadian clock function in the mammalian ovary.Ultra-low Doses of Follicle Stimulating Hormone and Progesterone Attenuate the Severity of Polycystic Ovary Syndrome Features in a Hyperandrogenized Mouse Model.Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.ATP synthase β-subunit abnormality in pancreas islets of rats with polycystic ovary syndrome and type 2 diabetes mellitus.Increase of kisspeptin-positive cells in the hypothalamus of a rat model of polycystic ovary syndrome.Developmental programming by androgen affects the circadian timing system in female mice.Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS.Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome.The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat's offspring in adulthood.High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome.Introducing a rat model of prenatal androgen-induced polycystic ovary syndrome in adulthood.Prior caloric restriction increases survival of prepubertal obese- and PCOS-prone rats exposed to a challenge of time-limited feeding and physical activity.Thymoquinone ameliorates some endocrine parameters and histological alteration in a rat model of polycystic ovary syndrome.Licorice ethanol extract improves symptoms of polycytic ovary syndrome in Letrozole-induced female rats
P2860
Q26745164-3D27C8F7-2A49-4DF7-AF98-710A59672F48Q26829866-E176AFB1-EF25-47DF-8BCF-D89C9FCDA5F3Q28066227-A66A624C-7C15-4C2C-B068-3961537E5263Q30357869-2A3F3104-DA25-4724-8380-65F1BC16E4FCQ33721736-3B8C9C32-BE8F-48EE-9AA8-C39DDABEC2F7Q34985720-C65C6156-FDF4-4AD3-8BF1-84D0AE4B21A1Q35114689-310A9C37-E15B-4D79-A63E-63BBFED63776Q35552267-BDE32A7E-7603-450C-814B-B797025EAF1BQ35834587-BBFD3743-E305-45E6-8994-203ABBF66024Q36125610-B3778F07-8B1D-4F68-9E3D-46029B5E6D62Q36292791-CC91C8E9-8150-4B9A-83EA-B16DC386B28EQ37067105-41A9026D-A71E-48F3-96AA-F3BD53346A06Q37264540-955BB4B6-6940-4A90-B4D6-33AEF6BEC443Q37635279-A12CBF4B-0577-4355-AE41-B1DCFA555CB7Q38264865-8E83EF77-FD72-4B1C-8C21-0D6DAED70CA4Q42698614-4FDC62A6-FDE1-4A3D-81A4-4C46EBA2792FQ45974242-22E62E28-6A9F-44F9-AC9F-81B08A71E2E4Q47797884-63A67873-E9FB-4E5F-BE4F-D9BB8916041AQ48916262-56AB5F6A-AC82-46D6-9F62-7A9873924DB9Q50600153-18A65F44-3411-4662-8F50-10707BE84792Q50872890-BF526CD8-1DBE-48A0-8687-9E39CA9AABB3Q51024084-37E89DC9-88F9-4F16-A4F5-D10EB2F46796Q51053064-41D7F410-A150-482E-A5BD-8C74F2761053Q51067996-9E913877-E7F3-49F4-82CA-102B471D16D7Q51122360-45B26578-A1E6-4410-BC97-6D7E35CC1962Q51160355-F219EC4C-B1F2-410C-98E7-C05DFA9E6B90Q51269847-4D9DE30A-C197-49F3-80F4-2D0BEEA12374Q55383734-245A1738-ED55-4A9D-8C35-9BA8F697F930Q57124496-B13750D0-1404-4AAE-AF5B-CD3EBFBA8883
P2860
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Animal models of polycystic ov ...... ypes and cardiometabolic risk.
@en
type
label
Animal models of polycystic ov ...... ypes and cardiometabolic risk.
@en
prefLabel
Animal models of polycystic ov ...... ypes and cardiometabolic risk.
@en
P1476
Animal models of polycystic ov ...... ypes and cardiometabolic risk.
@en
P2093
Donna F Vine
P304
P356
10.1016/J.FERTNSTERT.2012.04.006
P407
P577
2012-05-17T00:00:00Z